Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
Metsera, a biotech focused on obesity treatments, came out of stealth only this year, and its lead drug is still in early ...
Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related ...
The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...
Medpage Today on MSN12d
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1DThe FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once ...
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.
2hon MSN
Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...
Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...
After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback